MELODY TRANSCATHETER PULMONARY VALVE, ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM and ENSEMBLE II TRANSCATHETER VALVE D

Pulmonary Valve Prosthesis Percutaneously Delivered

FDA Premarket Approval P140017 S005

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the melody transcatheter pulmonary valve, ensemble transcatheter valve delivery system, and ensemble ii transcatheter valve delivery system for expanding the indications to include patients with a dysfunctional surgical bioprosthetic pulmonary valve. The device is indicated for use in the management of pediatric and adult patients who have a clinical indication for intervention on a dysfunctional right ventricular outflow tract (rvot) conduit or surgical bioprosthetic pulmonary valve that has >= moderate regurgitation and/or a mean rvot gradient >= 35 mmhg.

DeviceMELODY TRANSCATHETER PULMONARY VALVE, ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM and ENSEMBLE II TRANSCATHETER VALVE D
Classification NamePulmonary Valve Prosthesis Percutaneously Delivered
Generic NamePulmonary Valve Prosthesis Percutaneously Delivered
ApplicantMEDTRONIC Inc.
Date Received2016-09-01
Decision Date2017-02-24
Notice Date2017-03-10
PMAP140017
SupplementS005
Product CodeNPV
Docket Number17M-1227
Advisory CommitteeCardiovascular
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewYes
Combination Product No
Applicant Address MEDTRONIC Inc. 8200 Coral Sea Street Ne mvs83 mounds View, MN 55112
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140017Original Filing
S023 2022-11-16 30-day Notice
S022 2022-07-20 30-day Notice
S021 2022-02-28 30-day Notice
S020 2022-01-27 30-day Notice
S019 2021-07-29 30-day Notice
S018
S017 2019-10-01 30-day Notice
S016
S015 2019-06-20 30-day Notice
S014 2018-11-13 Normal 180 Day Track No User Fee
S013
S012 2018-10-01 30-day Notice
S011 2018-09-26 Real-time Process
S010 2017-12-01 30-day Notice
S009
S008 2017-09-11 30-day Notice
S007 2017-04-19 30-day Notice
S006 2016-11-23 Normal 180 Day Track No User Fee
S005 2016-09-01 Panel Track
S004 2016-04-25 Normal 180 Day Track
S003 2016-04-08 30-day Notice
S002 2016-03-23 30-day Notice
S001 2015-06-17 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00643169588455 P140017 000
00643169588448 P140017 000
00643169588431 P140017 000
00643169588196 P140017 000
00643169588189 P140017 000
00643169713895 P140017 004
00643169713901 P140017 004
00643169713888 P140017 004

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.